SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-014239
Filing Date
2014-08-05
Accepted
2014-08-05 14:52:57
Documents
14
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ahro20140630_10q.htm 10-Q 784084
2 EXHIBIT 3.1 ex3-1.htm EX-3 12320
3 EXHIBIT 10.1 ex10-1.htm EX-10 82069
4 EXHIBIT 10.2 ex10-2.htm EX-10 91945
5 EXHIBIT 31.1 ex31-1.htm EX-31 17615
6 EXHIBIT 31.2 ex31-2.htm EX-31 17601
7 EXHIBIT 32.1 ex32-1.htm EX-32 6585
8 EXHIBIT 32.2 ex32-2.htm EX-32 7395
  Complete submission text file 0001437749-14-014239.txt   5970235

Data Files

Seq Description Document Type Size
9 EXHIBIT 101.INS ahro-20140630.xml EX-101.INS 846612
10 EXHIBIT 101.SCH ahro-20140630.xsd EX-101.SCH 49450
11 EXHIBIT 101.CAL ahro-20140630_cal.xml EX-101.CAL 25321
12 EXHIBIT 101.DEF ahro-20140630_def.xml EX-101.DEF 258445
13 EXHIBIT 101.LAB ahro-20140630_lab.xml EX-101.LAB 378387
14 EXHIBIT 101.PRE ahro-20140630_pre.xml EX-101.PRE 252289
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

IRS No.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 141015798
SIC: 2834 Pharmaceutical Preparations